Bioequivalence Evaluation of a Folate-Supplemented Oral Contraceptive Containing Ethinylestradiol/Drospirenone/Levomefolate Calcium versus Ethinylestradiol/Drospirenone and Levomefolate Calcium Alone

被引：2
|
作者：
Herbert Wiesinger
Urte Eydeler
Frank Richard
Dietmar Trummer
Hartmut Blode
Beate Rohde
Konstanze Diefenbach
机构：
[1] Bayer HealthCare Pharmaceuticals,
[2] Scope International GmbH,undefined
[3] Nycomed GmbH — A Takeda Company,undefined
来源：
Clinical Drug Investigation | 2012年 / 32卷
关键词：
Folate; Folate Level; Folate Status; Study Drug Administration; Drospirenone;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Background: Neural tube defects (NTDs) are congenital malformations that occur during early embryonic development. Suboptimal maternal folate status is a well-known risk factor for the occurrence of NTDs, and periconceptional folic acid supplementation has been shown to reduce the risk of NTDs. Folate-supplemented oral contraceptives (OCs) offer a means of improving folate status in women of childbearing potential by increasing their likelihood of having raised folate levels at the time of conception.
引用
收藏
页码：673 / 684
页数：11
相关论文
共 30 条
  • [1] Bioequivalence Evaluation of a Folate-Supplemented Oral Contraceptive Containing Ethinylestradioli Drospirenone/Levomefolate Calcium versus Ethinylestradiol/Drospirenone and Levomefolate Calcium Alone
    Wiesinger, Herbert
    Eydeler, Urte
    Richard, Frank
    Trummer, Dietmar
    Blode, Hartmut
    Rohde, Beate
    Diefenbach, Konstanze
    CLINICAL DRUG INVESTIGATION, 2012, 32 (10) : 673 - 684
  • [2] Bioequivalence study of an oral contraceptive containing ethinylestradiol/drospirenone/levomefolate calcium relative to ethinylestradiol/drospirenone and to levomefolate calcium alone
    Blode, Hartmut
    Klipping, Christine
    Richard, Frank
    Trummer, Dietmar
    Rohde, Beate
    Diefenbach, Konstanze
    CONTRACEPTION, 2012, 85 (02) : 177 - 184
  • [3] EE-drospirenone-levomefolate calcium versus EE-drospirenone
    Diefenbach, Konstanze
    Trummer, Dietmar
    Ebert, Frank
    Lissy, Michael
    Koch, Manuela
    Rohde, Beate
    Blode, Hartmut
    INTERNATIONAL JOURNAL OF WOMENS HEALTH, 2013, 5 : 149 - 163
  • [4] The use of an oral contraceptive containing ethinylestradiol and drospirenone in an extended regimen over 126 days
    Foidart, JM
    Sulak, PJ
    Schellschmidt, I
    Zimmermann, D
    CONTRACEPTION, 2006, 73 (01) : 34 - 40
  • [5] Effects of low dose oral contraceptive pill containing drospirenone/ethinylestradiol in patients with endometrioma
    Taniguchi, Fuminori
    Enatsu, Akiko
    Ota, Ikuko
    Toda, Toshiko
    Arata, Kazuya
    Harada, Tasuku
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2015, 191 : 116 - 120
  • [6] The pharmacokinetics and pharmacodynamics of dehydroepiandrosterone during use of an ethinylestradiol- and drospirenone-containing oral contraceptive
    Zimmerman, Yvette
    Bennink, Herjan J. T. Coelingh
    Wouters, Wout
    Ebes, Frieda
    Fauser, Bart C. J. M.
    EUROPEAN JOURNAL OF CONTRACEPTION AND REPRODUCTIVE HEALTH CARE, 2013, 18 (06): : 489 - 500
  • [7] Efficacy and tolerability of a monophasic oral contraceptive containing ethinylestradiol and drospirenone (vol 5, pg 61, 2000)
    Huber, J
    Foidart, JM
    Wuttke, W
    Merki-Field, GS
    The, HS
    Gerlinger, C
    Schellschmidt, I
    Heithecker, R
    EUROPEAN JOURNAL OF CONTRACEPTION AND REPRODUCTIVE HEALTH CARE, 2001, 6 (01): : 63 - 63
  • [8] Sexual behavior of women using an oral contraceptive containing 30 μg ethinylestradiol and 3 mg drospirenone
    Caruso, S
    Agnello, C
    Intelisano, G
    Farina, M
    Di Maria, L
    Sparacino, L
    Cianci, A
    HUMAN REPRODUCTION, 2005, : 847 - 851
  • [9] Evaluation of effects of an oral contraceptive containing ethinylestradiol combined with drospirenone on adrenal steroidogenesis in hyperandrogenic women with polycystic ovary syndrome
    De Leo, Vincenzo
    Morgante, Giuseppe
    Piomboni, Paola
    Musacchio, Maria Concetta
    Petraglia, Felice
    Cianci, Antonio
    FERTILITY AND STERILITY, 2007, 88 (01) : 113 - 117
  • [10] Combined contraceptive ring versus combined oral contraceptive (30-μg ethinylestradiol and 3-mg drospirenone)
    Mohamed, Ahmed M. M.
    El-Sherbiny, Wael S. M.
    Mostafa, Walaa A. I.
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2011, 114 (02) : 145 - 148
123